XBIT: XBiotech Inc. Stock

by  •  • Comments Off on XBIT: XBiotech Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 90.55
Enterprise Value ($M) -55.10
Book Value ($M) 174.71
Book Value / Share 5.73
Price / Book 0.52
NCAV ($M) 150.53
NCAV / Share 4.94
Price / NCAV 0.60

Profitability (mra)
Return on Invested Capital (ROIC) -0.21
Return on Assets (ROA) -0.17
Return on Equity (ROE) -0.19

Liquidity (mrq)
Quick Ratio 29.15
Current Ratio 29.15

Balance Sheet (mrq) ($M)
Current Assets 157.69
Assets 181.86
Liabilities 7.15
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -42.47
Net Income -38.53
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -30.96
Cash from Investing -1.30
Cash from Financing 10.45

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
01-27 13G/A Mckenzie W Thorpe 9.71 0.55
01-27 13G/A Simard John 19.90 0.19

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2025-04-29 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1)
2025-03-18 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ☐ Transaction Report pursuant to Sect
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-15 2,804 22,983 12.20
2025-05-14 6,036 28,521 21.16
2025-05-13 9,586 26,698 35.91
2025-05-12 9,347 56,239 16.62

(click for more detail)

Similar Companies
VTRS – Viatris Inc. VTYX – Ventyx Biosciences, Inc.
VYGR – Voyager Therapeutics, Inc. XERS – Xeris Biopharma Holdings, Inc.
XLO – Xilio Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io